COVID FLiRT variants KP.3 and XEC: What you need to know
KP.3 was the 'predominant' SARS-CoV-2 variant in the US. It was also spreading in Europe. It's now joined with another ...
Hybrid COVID variant XEC is more contagious: What to know about the new strain
The variant, which first appeared in Berlin in late June, has increasingly seen hundreds of cases in Germany, France, Denmark ...
New XEC COVID variant is on the rise. What are its symptoms, and what states is it in?
The new "XEC" COVID-19 variant spreading rapidly in Europe has arrived in the US. What are the symptoms, will it cause a fall ...
New COVID-19 variant making its way to California: What to know about XEC variant
Omicron variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of COVID-19 cases between Sept. 1 and Sept. 14. However, XEC and a variant known as MV.1 seem poised to become the next ...
Too Old to Operate9d
Real-Time Estimation of Omicron Variant Parameters Using Genomic Data
The following is a summary of “A two-variant model of SARS-COV-2 transmission: estimating the characteristics of a newly emerging strain,” published in the September 2024 issue of Infectious Diseases ...
New Covid XEC variant starting to spread in Europe – what we know about signs and symptoms
XEC, a sublineage of the omicron variant, was first reported in Berlin, Germany, in June and is now spreading “quite rapidly” ...
The Globe and Mail17d
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
A report from Transparency Market Research said that: “the emergence of new variants of coronavirus ... activity towards at least 4 strains of VOC including WA1/2020, Gamma (P.1), Delta (B.1.617.2), ...
The Lancet10d
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
Our study shows the feasibility of real-time estimation of antibody kinetics before SARS-CoV-2 variant emergence. This estimation is valuable for understanding how specific combinations of SARS-CoV-2 ...
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 - The Globe and Mail
COVID-19’s impact on global society would be felt for a long time. Nonetheless, significant investment in life sciences in the last few decades has facilitated a rapid scientific response through ...